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Abstract
Background: While there are compelling observational data confirming that individuals who
exercise are healthier, the efficacy of aerobic exercise interventions to reduce metabolic risk and
improve insulin sensitivity in older people has not been fully elucidated. Furthermore, while low
birth weight has been shown to predict adverse health outcomes later in life, its influence on the
response to aerobic exercise is unknown. Our primary objective is to assess the efficacy of a fully
supervised twelve week aerobic exercise intervention in reducing clustered metabolic risk in
healthy older adults. A secondary objective is to determine the influence of low birth weight on the
response to exercise in this group.
Methods/Design: We aim to recruit 100 participants born between 1931–1939, from the
Hertfordshire Cohort Study and randomly assign them to no intervention or to 36 fully supervised
one hour sessions on a cycle ergometer, over twelve weeks. Each participant will undergo detailed
anthropometric and metabolic assessment pre- and post-intervention, including muscle biopsy,
magnetic resonance imaging and spectroscopy, objective measurement of physical activity and sub-
maximal fitness testing.
Discussion: Given the extensive phenotypic characterization, this study will provide valuable
insights into the mechanisms underlying the beneficial effects of aerobic exercise as well as the
efficacy, feasibility and safety of such interventions in this age group.
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Numerous studies have shown that physically active indi-
viduals tend to be healthier. Aerobic fitness and habitual
physical activity are associated with reduced all-cause
mortality, metabolic risk and cardiovascular disease, even
in very active individuals [1-4]. Longitudinal cohort stud-
ies have confirmed that changes in physical activity are
reflected in altered metabolic risk and mortality over time
[5]. Trials of interventions to increase physical activity and
fitness among older people have tended to be restricted to
specific high-risk subgroups. Several trials have shown
that lifestyle interventions reduce the risk of progression
to diabetes in individuals with impaired glucose tolerance
(IGT) and that the beneficial effects of such interventions
persist for several years [6-8]. Exercise interventions also
reduce cardiovascular and all-cause morbidity and mor-
tality and lead to subjective improvements in quality of
life, even in older individuals with established vascular
disease [9,10].
While at-risk populations such as those with IGT or vascu-
lar disease have been shown to benefit from exercise pro-
grammes, the efficacy of such interventions to improve
health in the general population remains unproven. In
particular, strong evidence that aerobic exercise interven-
tions are beneficial in healthy older people is lacking. Not-
withstanding this, public health initiatives encourage
people to exercise at least five times per week, irrespective
of age or disease risk [11]. While such encouragement
seems reasonable given our current knowledge of the ben-
efits of physical activity from observational studies, the
evidence base for aerobic exercise interventions in healthy
older people ought to be more robust. In practice, old age
is often an exclusion criterion for such studies.
Many previous studies that have assessed aerobic exercise
interventions have yielded physiologically informative
data but have inherent methodological limitations in
terms of assessing the efficacy of these interventions per
se. Some compare different exercise modalities, without
including a true "control" group [12]. Where studies have
included controls, often only within-group comparisons
are reported, rather than considering changes in outcomes
in exercisers in the context of changes in the control group
[13]: Using the latter approach allows consideration of
any measurement effect and would yield a more valid
measure of the efficacy of such interventions. Some effi-
cacy analyses have not included study dropouts, or report
only on participants who adhered to the intervention in
question, rather than conducting an intention-to-treat
analysis [14]. Often, attrition rates from exercise interven-
tions are high, thus reducing power [15]. Indeed, inade-
quate power is frequently cited as an explanation for
negative findings in these studies, even where participant
retention has been good [16,17].
Some people respond better than others to aerobic exer-
cise interventions in relation to reductions in body fat,
improved fitness and changes in metabolic parameters.
Several factors underlie this heterogeneity in the response
to exercise. In the diabetes prevention trials, older partici-
pants gained more benefit from lifestyle interventions
than younger ones did [8,18]. Certain genotypes are
known to affect the metabolic response to exercise [19].
Individuals with a family history of diabetes derive more
benefit from exercise than those without such a history
[20]. Metabolic improvements associated with exercise
are more pronounced in those with higher metabolic risk
[21]. However the factors that influence the response to
aerobic exercise in healthy older individuals have not
been fully described.
Low Birth Weight, Fitness and Metabolic Risk
The thrifty phenotype hypothesis proposes that an
adverse intrauterine environment (as manifest by a low
birth weight) leads to alterations in the structure and func-
tion of various tissues that ultimately confer an increased
risk of certain chronic diseases later in life [22]. These
alterations arise only when environmental influences
occur during certain critical periods of development,
when the organism is sensitive to such influences. Studies
among individuals exposed to the Dutch "hunger winter"
famine of 1944–45 showed that the babies of mothers
who were exposed to famine in mid- or late-gestation
were born smaller and subsequently had lower glucose
tolerance as adults than those whose mothers were only
exposed to famine in early gestation or not at all [23]. In
animal models, diet restriction in utero or prior to wean-
ing reduces longevity, while dietary restriction after wean-
ing has the opposite effect [24]. Thus, the same
environmental exposure can lead to different outcomes,
depending on the phase of development in which it
occurs. The emergence of programmed changes is modi-
fied by adult life factors such as obesity, ageing and phys-
ical activity. The highest cardiovascular risk is seen in
people who are born small but become overweight as
adults [25]. In rural Gambia, even severe malnutrition in
early childhood did not lead to adverse metabolic profiles
in adults who were lean, fit and consuming a low fat diet
[26]. Hence the impact of pre- and post-natal growth on
adult disease risk must be considered in the context of
adult environmental exposures.
Body fat distribution is a key determinant of cardiovascu-
lar risk and foetal growth restriction is known to impact
on fat deposition in utero, leading to central adiposity
later in life [27,28]. Whether such changes in body fat dis-
tribution persist into late adulthood is unknown. Chil-
dren born small who showed catch-up growth in the first
two years of life had a higher percentage body fat and
more central adiposity compared to normal birth weightPage 2 of 9
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quent lean mass at different ages, independently of gesta-
tional age, and has been shown to correlate with grip
strength in older individuals [30,31]. While aerobic fit-
ness is known to reduce cardiovascular risk, it also modu-
lates the association between small size at birth and
cardiovascular risk, such that the risk associated with low
birth weight is more pronounced in less fit individuals [3].
The association between birth weight and muscle strength
persists independently of muscle mass, suggesting that
cellular and molecular mechanisms are also modulated
by birth weight [32]. Whether aerobic exercise-induced
changes in muscle function are differential with respect to
birth weight is not known. A previous observational study
suggested that exercise has a protective effect against pro-
gression to diabetes in low birth weight individuals [33],
but higher level evidence from intervention studies is cur-
rently lacking.
Myocellular and hepatic lipid deposition
Skeletal muscle is the major site of insulin mediated glu-
cose disposal. Lipid accumulation in skeletal muscle is
strongly implicated in the pathogenesis of insulin resist-
ance and type 2 diabetes [34]. Impaired mitochondrial
oxidative phosphorylation may also contribute to this
problem [35]. Magnetic resonance spectroscopy studies
have suggested that intramyocellular lipid content (IMCL)
is a major determinant of muscle insulin sensitivity [36].
Exercise modulates several metabolic pathways in skeletal
muscle, enhancing glucose uptake and glycogen synthesis
and inducing mitochondrial biogenesis. However, exer-
cise has been shown to increase IMCL, and elevated IMCL
levels have been found in endurance trained athletes,
despite normal insulin sensitivity [37,38]. Potentially,
IMCL is a marker for other lipid intermediates know to
suppress insulin sensitivity rather than having a direct
insulin desensitising effect in muscle per se [39]. Exercise
induced changes in muscle metabolic pathways have pre-
viously been shown to markedly improve glucose uptake
and mitochondrial function, in all age groups [13].
Whether exercise-induced changes in IMCL in older peo-
ple are modulated by birth weight has not previously been
determined.
Hepatic fat deposition is also a major determinant of insu-
lin sensitivity. While one study in rats suggested that con-
current exercise may prevent liver steatosis induced by a
high fat diet, other animal studies suggest there is no exer-
cise effect [40,41]. Similar negative findings have recently
emerged in human studies [42]. The effect of aerobic exer-
cise on intrahepatic lipid (IHL) stores in older individuals
has not previously been described. MR spectroscopy is
considered the best non-invasive method for quantifying
intrahepatic lipid content [43]. However, the technique is
relatively time consuming and expensive. The search for
more practical alternative methods for detecting liver stea-
tosis has begun in earnest, and ultrasound has shown
promise in this regard [44]. Whether it is a reliable
method for quantifying milder degrees of liver fat deposi-
tion remains to be determined. A secondary objective of
this study is to assess the reliability, validity and feasibility
of ultrasound measures of liver steatosis that may subse-
quently be applied in larger epidemiological studies.
As individuals get older, body weight declines primarily
because of loss of lean tissue [45], while IMCL and liver
steatosis tend to increase [46]. The decline in muscle mass
results from loss of protein content and individual muscle
fibres with a preferential atrophy of type II or fast twitch
fibres [47]. The inverse relationship between age and
physical activity may account for reduced muscle function
in older people [48]. Whether interventions to increase
physical activity have an effect on muscle structure and
function in this age group has not previously been
described. Furthermore, how birth weight affects the rela-
tionship between muscle function and physical activity
remains unknown.
Methods/Design
Study design
This is a single centre, explanatory randomized controlled
trial of the efficacy of a fully supervised twelve-week aero-
bic exercise intervention to reduce overall metabolic risk
in healthy older people. Participants are randomized to
exercise or control groups following minimisation accord-
ing to birth weight, percentage body fat, gender and
whether or not a muscle biopsy has been performed. The
duration of follow-up is 12 weeks from study entry.
Setting
All baseline and follow-up measures for the trial are con-
ducted at the MRC Epidemiology Unit in the Institute of
Metabolic Science in Cambridge. The aerobic exercise
intervention is delivered at a gymnasium in Hitchin, Hert-
fordshire. The study has been approved by the Hertford-
shire Research Ethics Committee (LREC reference number
05/Q0201/23).
Study Population
Participants have been recruited from the Hertfordshire
Cohort Study, a unique data resource consisting of men
and women born between 1931–39 and still residing
there, each of whom had measures of birth weight and
growth at one year recorded in infancy [49]. Specifically,
we have identified 674 potential study participants within
this cohort who live in or near Hitchin, in close proximity
to the training facility (see figure 1). We have approached
each potential participant's general practitioner to ensure
that an invitation to the study is appropriate. Then, an
invitation letter and information sheet is despatched,
detailing the requirements of study participation and the
procedures involved. For those who have agreed to partic-Page 3 of 9
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research facility at Addenbrooke's hospital in Cambridge,
after an overnight fast. All procedures are carried out in
accordance with the principles of good clinical practice.
Fully informed written consent is obtained from each par-
ticipant prior to testing.
Exclusion criteria
Individuals with known diabetes, untreated or unstable
ischaemic heart disease or any medical condition that
would prevent them cycling unaided for at least thirty
minutes are excluded from the trial. Those with claustro-
phobia, cardiac pacemakers or metal implants are pre-
cluded from magnetic resonance scanning but have all
other study measures taken. Participants taking anticoag-
ulant medication such as warfarin and clopidogrel are
excluded from the muscle biopsy procedure.
Measurements
Anthropometry
Weight is measured on a Tanita® scale and height with a
Seca® wall-mounted stadiometer. Waist and hip circumfer-
ences are measured using a D-loop non-stretch fibreglass
tape measure. The waist is defined as the mid-point
between the lower costal margin and the level of the supe-
rior iliac crests. The hip measurement is taken at the level
of the greater trochanter. Blood pressure is measured with
an automated oscillometric device (Omron®) using the
right arm, after participants are seated quietly for five min-
utes. Three measures are recorded at one-minute intervals.
A 12-lead electrocardiogram is performed to exclude
occult ischaemic heart disease or cardiac arrhythmia.
Dual Energy X-Ray Absorbtiometry (DEXA)
In order to quantify overall and regional changes in body
composition, a DEXA scan (Lunar Prodigy Advanced, GE
Healthcare) is performed to measure lean mass, fat mass
and bone mineral density [50]. Software (enCORE™, GE
Healthcare) is used to derive whole body fat percentage,
after scan acquisition.
Ultrasound
A LOGIQ Book XP® ultrasound device (GE Healthcare)
with a 3C-RS curved transducer is used to assess liver
parenchymal density relative to renal parenchymal den-
sity, as a marker of fatty infiltration. A semi-quantitative
grading system is used to define normal echotexture or
mild, moderate and severe steatosis. Additionally, ultra-
sonography is used to quantify abdominal visceral and
subcutaneous fat depots. The depth of fat tissue at waist
level on the anterior abdominal wall, and the distance
between the vertebral bodies and rectus abdominis are
taken to represent subcutaneous and visceral fat depots,
respectively.
Magnetic Resonance Spectroscopy and Imaging
Magnetic resonance measures of IHL, IMCL, visceral- and
subcutaneous- adipose tissue (VAT, SCAT) are conducted
on a whole body Siemens 3T Tim® Trio scanner at the
Wolfson Brain Imaging Centre on the Addenbrooke's
campus. For IHL, a 1H spectrum is obtained from a voxel
of cube length 1.5 cm, located within the posterior aspect
of the right lobe of the liver, using the point resolved selec-
tive spectroscopy (PRESS) sequence. During this measure-
ment, participants are given breathing instructions with a
7-second cycle, which is designed and gated such that
localisation and subsequent data acquisition occur at the
end of expiration. Non-water suppressed data are
acquired with repetition time (TR) = 7 s, echo time (TE) =
35 ms and averaged over 64 measures. The voxel is posi-
tioned to avoid blood vessels and the biliary tree, using T2-
weighted HASTE transaxial images that are also acquired
in the same phase of respiration. The voxel is placed in the
same location at the participant's follow-up visit. For
IMCL measures, localisation images are acquired in three
orthogonal directions through the right lower leg. To aid
voxel relocation at the follow-up visit and to ensure the
transaxial slices are acquired through the largest bulk of
the soleus muscle, the localisation images are planned
such that the top of the medial femoral condyle is located
Flow Chart for the recruitment phase of the Hertfordshire Birth ohort Physical Activity Trialgure 1
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located within the transaxial slice that contains the most
homogenous soleus muscle bulk, avoiding fascial lines
and visible fat tissue. A water-suppressed spectrum is
obtained using the PRESS sequence with TR = 5 s, TE = 35
ms and 64 averages. All spectra are analysed jMRUI [51]
and fitted using the AMARES [52] algorithm with prior
knowledge. IHL and IMCL are quantified relative to water
and creatine, respectively. Magnetic resonance imaging
(MRI) is then used to measure abdominal fat depots in a
transverse section. The L4 vertebral body is placed at the
isocentre of a 17-slice, T1-weighted image with turbo spin
echo and water suppression. Transaxial slice thickness is
10 mm with a 2-mm gap. Imaging parameters used are a
field of view of 500 × 500 mm, in-plane resolution of 1.3
× 1.3 mm, TR = 400 ms, TE = 21 ms and two averages.
Cross-sectional volumes of VAT and SCAT are calculated
using a semi-automated method, incorporating a soft-
ware-generated threshold map (Analyze 7.0, BIR, Mayo
Clinic, Rochester MN) which is used in combination with
manual input to distinguish the two fat compartments.
Blood Samples and Oral Glucose Tolerance Test
A standard 75 g oral glucose tolerance test (OGTT) is per-
formed. Fasting samples are taken for glucose, insulin, C-
peptide, liver and lipid profiles. Additional samples are
immediately centrifuged and stored at -80°C for subsequent
analyses. After ingestion of glucose, further samples are taken
every 30 minutes over two hours. The Homeostasis Model
Assessment (HOMA) [53] is used to estimate "basal" insulin
sensitivity, while the Oral Glucose Insulin Sensitivity (OGIS)
model [54] determines "stimulated" sensitivity based on
dynamic insulin responses during the OGTT.
Muscle Biopsy
Biopsies are taken from the right vastus lateralis muscle
with a modified Bergstrom needle (5 mm), using a fully
aseptic technique under local anaesthetic. The samples are
quickly dried on sterile gauze and then immediately snap
frozen in liquid nitrogen for subsequent analysis.
Physical Performance Battery and Aerobic Fitness
This validated battery of tests involves assessing five com-
ponents of basic motor function in older people, namely
dominant arm grip strength, time taken to rise from a
chair and walk a short distance, repeated chair rises, cus-
tomary walking speed and balance [55-57]. A sub-maxi-
mal exercise test is performed on a cycle ergometer, with a
starting workload of 50 Watts (W), increasing by 10 W
every minute until 90% of the maximum age-predicted
heart rate is achieved or the participant wants to stop. The
volume of expired air (VE), carbon dioxide (VCO2) and
oxygen consumption (VO2) is measured at rest for ten
minutes prior to exercise, during the test and then for the
first five minutes of the recovery phase. An open-circuit
respiratory gas analysis system (Jaeger Oxycon Pro®),
which has been validated elsewhere is used for these
measures [58].
Objective Measures of Habitual Physical Activity
In order to objectively estimate average daily physical
activity energy expenditure (PAEE), each participant wears
a combined heart rate and movement sensor (Actiheart®,
CamNtech, Cambridge UK) continuously for one week
[59]. The heart rate response to the sub-maximal exercise
test is used for individual calibration of the device [60]
and branched equation modelling is then utilised to esti-
mate PAEE [61]. This approach has high validity for esti-
mating the intensity of physical activity [62,63].
Participants wear the Actiheart® for one week after their
initial study visit (prior to starting the exercise interven-
tion), then again six weeks later, and finally for a third
time after the completion of the last study visit.
Questionnaires
A general questionnaire is used to record details of current
medications, smoking and alcohol use and dietary pat-
terns. It incorporates the SF-8™ (©1998, 1999 QualityMet-
ric Inc., Lincoln, RI), a validated measure of self perceived
health status [64]. A detailed family history questionnaire
allows the proportion of first degree relatives with diabe-
tes mellitus to be accurately determined. A Recent Physical
Activity Questionnaire (RPAQ) is also administered. This
quantifies physical activity in four different domains of
life (occupation, transportation, home/household and
recreational activity) over the preceding month and is
modelled on the EPAQ2 questionnaire that our group has
validated previously [65]. RPAQ has not previously been
validated in older people and so a secondary objective in
this study is to do so against the objective measures of
physical activity derived from combined heart rate and
movement sensing.
Exercise Intervention
Participants attend the exercise facility for three 1-hour
sessions per week over twelve weeks, on Monday,
Wednesday and Friday mornings or afternoons. All ses-
sions are fully supervised by the exercise facilitator, and
incorporate a warm-up and cool-down period. Partici-
pants use upright or recumbent cycle ergometers to
achieve an exercise intensity of 50, 60 and 70% of
VO2max during weeks 1–4, 5–8 and 9–12 of the interven-
tion, respectively. To ensure that the appropriate intensity
is maintained during the sessions, heart rate is monitored
(Polar Accurex Plus™) and recorded at five minute inter-
vals. For participants on betablockers, the Borg scale [66]
is used to assess the intensity of exercise. For those rand-
omized to the exercise intervention, their follow-up visit
to the testing facility is scheduled for exactly two days after
completion of their final exercise session.Page 5 of 9
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Outcomes
The primary outcome is the composite metabolic risk
score (zMS) measured at follow-up. This risk score is
derived by standardising and then summing the following
variables to create a standardised score: (Systolic blood
pressure + diastolic blood pressure)/2, log 2-hour plasma
glucose, log fasting insulin, inverted fasting HDL choles-
terol, log triglycerides and waist circumference. Each com-
ponent variable is standardised using sex-specific means
and standard deviations from the larger Hertfordshire
Cohort Study population from which these participants
were recruited, excluding those with prevalent diagnosed
diabetes.
There are several secondary outcome variables, including
aerobic fitness, PAEE, total energy expenditure, time spent
at different activity intensity levels, blood pressure and
resting heart rate. Metabolic secondary outcomes include
glucose, insulin and C-Peptide measures during the
OGTT, fasting proinsulin: split proinsulin ratios, leptin
and adiponectin levels, liver steatosis, IMCL, lipid pro-
files, indices of insulin sensitivity and glucose tolerance
status. Anthropometric outcomes include body weight, fat
mass, fat free mass, BMI, waist: hip ratio and visceral: sub-
cutaneous abdominal fat ratios. Additional outcomes
include perceived health, perceived quality of life and die-
tary patterns.
Sample Size
With 50 individuals randomized to each of the interven-
tion and control groups, this study will have 85% power
to detect a difference in mean zMS risk score of 0.6 stand-
ard deviation units between groups at follow-up. This is
consistent with our previous observational findings from
similar cohorts [2] and assumes that the risk score at fol-
low-up in the control group has a mean of 0 and a stand-
ard deviation of 1.
Definition of Analysis Populations
For the primary trial efficacy analysis, the intention to
treat population includes all participants who were rand-
omized. Then, a per-protocol analysis includes all partici-
pants from the control group, but only those intervention
participants who completed 85% or more of their pre-
scribed exercise sessions. For certain outcomes, sensitivity
analyses will be performed with other subsets of partici-
pants excluded, e.g. heart rate responses in those on beta-
blockers.
Analysis of the primary outcome
The primary analysis compares the composite metabolic
risk score at follow-up, adjusted for baseline, between the
intervention and control groups. A linear regression
model will be used, with follow-up risk score as the out-
come and baseline risk score as a covariate.
Analysis of the secondary outcomes
The method used to analyse the primary outcome will
also be used to analyse the secondary outcomes. For out-
comes which do not have a normal distribution, a log
transformation will be applied.
Missing data
Individuals with a missing value for an outcome variable
at follow-up will be excluded from the analysis of that var-
iable. Where the baseline value of a particular outcome is
missing, the missing indicator method [67] will be used in
sensitivity analyses.
Exploratory Analyses
In exploratory analyses, the linear regression model
described above will be extended to include an interaction
between birth weight and randomized group, to assess
whether the effect of the intervention differs according to
birth weight. Although this is a randomized trial, there
may be some covariates which are not sufficiently well
balanced between the exercise and control groups, and
where this occurs, these will be considered as potential
confounders in subsequent analyses.
Discussion
Compelling observational data suggest that older people
who engage in exercise are fitter and healthier and have
lower cardiovascular risk, but higher level evidence that
exercise interventions are beneficial in this group is cur-
rently lacking. This study will assess the efficacy of such an
intervention to improve composite metabolic risk and
other endpoints such as glucose tolerance status and insu-
lin sensitivity. The feasibility and safety of a fully super-
vised, gym-based aerobic exercise programme will also be
determined. The extent to which supervised exercise influ-
ences habitual physical activity levels will also be
explored, as previous work has suggested that compensa-
tory reductions in non-exercise physical activity in older
people might negate any benefits [68]. We have not
included a dietary modification component to this life-
style intervention, as to do so may introduce uncertainty
as to the mechanisms underlying any observed metabolic
improvements. Furthermore, there is some evidence that
exercise alone is superior to combined exercise and dietary
interventions [69], although other studies suggest com-
bined interventions are best [70]. Observational findings
that low birth weight increases subsequent metabolic risk
only in adults who are less fit suggests that exercise may
have greater benefits in low birth weight individuals [3].
This study is well placed to elucidate any interactions
between birth weight and the metabolic response to aero-
bic exercise, given the relatively large number of partici-
pants and the extensive physiological characterization
that is involved. This will also allow assessment of other
potential determinants of exercise responses, such as dia-
betes family history. The study will provide valuablePage 6 of 9
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body composition and physical activity energy expendi-
ture, both of which are critically important epidemiologi-
cal outcomes. In addition to a trial efficacy analysis,
subsequent cohort analyses will allow the exploration of
the effects of birth weight on responses to changes in fit-
ness and body composition. The findings will consolidate
our understanding of the putative benefits of exercise in
older people, and the mechanisms through which they
occur.
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